AwardedBelgiumGoods
Spécialités pharmaceutiques à base de ECULIZUMAB et de RAVULIZUMAB
- Published
- Published 4 August 2025
- Deadline
- Closed 18 September 2025
Overview
Les nouveaux patients feront l’objet de ce marché public, les patients actuellement sous traitement ne doivent pas obligatoirement en changer. Le médecin gardera la possibilité d’utiliser la molécule la mieux adaptée aux besoins du patient.
Key details
- Country
- Belgium
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 4 August 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- €2,520,000
- Award date
- 6 November 2025
- Contract period
- — → 14 October 2029
- AMGEN
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
12 November 2025
Contract Notice
4 August 2025
Contracting authority
Healthcare Public Procurement (HeCaPP)
Procuring entitySaint-Gilles\Sint-Gillis, Belgium
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.